Financial Gravity Asset Management’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
MBAM
OM
Financial Gravity Asset Management's IRD Position: Q3 2025 in Review
Financial Gravity Asset Management sold out of Opus Genetics (IRD) in Q3 2025, closing a stake of 16,555 shares — an estimated $15.6K sold.
Financial Gravity Asset Management first reported a position in IRD in Q4 2024 and held it in 3 quarters. The position peaked at $19.7K in Q4 2024. 48 funds tracked by Wall St. Rank hold IRD as of Q3 2025.
- Financial Gravity Asset Management reported no remaining Opus Genetics position as of Q3 2025 after selling out during the quarter.
- Financial Gravity Asset Management sold 16,555 Opus Genetics shares in Q3 2025, an estimated $15.6K.
- Financial Gravity Asset Management first reported a position in Opus Genetics in Q4 2024 and held it in 3 quarters.
- Financial Gravity Asset Management's Opus Genetics position peaked at $19.7K in Q4 2024.
- 48 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2025.
Based on Financial Gravity Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.